BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9034999)

  • 1. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
    Buchwald D; Wener MH; Pearlman T; Kith P
    J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL; Lin JM; Reeves WC
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
    ter Wolbeek M; van Doornen LJ; Kavelaars A; van de Putte EM; Schedlowski M; Heijnen CJ
    Brain Behav Immun; 2007 Nov; 21(8):1063-74. PubMed ID: 17544255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome.
    Spence VA; Kennedy G; Belch JJ; Hill A; Khan F
    Clin Sci (Lond); 2008 Apr; 114(8):561-6. PubMed ID: 18031285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.
    Orre IJ; Murison R; Dahl AA; Ueland T; Aukrust P; Fosså SD
    Brain Behav Immun; 2009 Aug; 23(6):868-74. PubMed ID: 19362138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome.
    Buchwald D; Ashley RL; Pearlman T; Kith P; Komaroff AL
    J Med Virol; 1996 Sep; 50(1):25-30. PubMed ID: 8890037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care.
    Darbishire L; Ridsdale L; Seed PT
    Br J Gen Pract; 2003 Jun; 53(491):441-5. PubMed ID: 12939888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.
    Clements PJ; Peter JB; Agopian MS; Telian NS; Furst DE
    J Rheumatol; 1990 Jul; 17(7):908-10. PubMed ID: 2213757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
    Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
    J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal inflammation and fatigue experiences following colorectal surgery: a pilot study.
    Paddison JS; Booth RJ; Fuchs D; Hill AG
    Psychoneuroendocrinology; 2008 May; 33(4):446-54. PubMed ID: 18258374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognosis of patients with chronic fatigue vs chronic fatigue syndrome.
    Bombardier CH; Buchwald D
    Arch Intern Med; 1995 Oct; 155(19):2105-10. PubMed ID: 7575071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
    Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fatigue syndrome and other fatiguing illnesses in adolescents: a population-based study.
    Jones JF; Nisenbaum R; Solomon L; Reyes M; Reeves WC
    J Adolesc Health; 2004 Jul; 35(1):34-40. PubMed ID: 15193572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.